Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by cher0424 – China, 2015-01-08 07:28 (3831 d 22:43 ago) – Posting: # 14243
Views: 30,335

Dear Detlew

❝ Since according to 1. a subject with two periods, each with reference, will not be included in the pharmacokinetic analysis it can't be included in the statistical analysis (of whatever) since no PK metrics are available.


Thank you for your response.
One more query, why a subject with two periods, each with reference, will not be included in the pharmacokinetic analysis for SWR?

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,676 registered users;
25 visitors (0 registered, 25 guests [including 15 identified bots]).
Forum time: 07:12 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5